Posts Tagged: "kevin noonan"

Scott Kieff: “My biggest take from today’s sessions, was to hear from Don Dunner and Judge Newman and others about that great ideas that we could all share in to bring increased economic growth, increased innovation, increased opportunity for the market, for consumers and for manufacturing by returning to an approach to the IP Antitrust interface that is politically diverse, that both President’s Carter and Reagan embraced. That kind of pivoting could really help the system and it could be done by getting professionals within the community to just talk together in a different way. I know that sounds small because it’s just talking, and talking in a different way. But sometimes those little things can have big payoffs.”

Trade partners negotiating the Tans-Pacific Partnership trade deal have reached an agreement. The agreement details have not been released, and likely will not be submitted to Congress for a mandatory review for at least a month, perhaps longer… Presently the United States provides 12 years of data exclusivity for these types of medicines, but the TPP agreement reportedly knocks that term of protection down to 5 years. While the term of data exclusivity is not one in the same with reducing the term of market exclusivity, there is little doubt that more limited data exclusivity would likely lead to significant negative consequences for the bio-pharma industry.